{"id":59954,"date":"2024-02-28T06:25:37","date_gmt":"2024-02-28T06:25:37","guid":{"rendered":"https:\/\/medsname.com\/palip-xr\/"},"modified":"2026-04-30T10:23:52","modified_gmt":"2026-04-30T10:23:52","slug":"palip-xr","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/palip-xr\/","title":{"rendered":"Palip XR"},"content":{"rendered":"

<\/p>\n

\n

\u26a1 Gyors v\u00e1lasz<\/h3>\n

Palip XR (Paliperidone 3 \/ 6 \/ 9 mg XR, extended-release) is an atypical antipsychotic for schizophrenia and schizoaffective disorder. Active metabolite of risperidone, dosed once daily via OROS osmotic-pump tablet. Largely renally cleared \u2014 dose-adjust in renal impairment.<\/p>\n<\/div>\n

\nMit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n

\ud83d\udce6 Minden rendel\u00e9st fedez a \u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n

Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n

Palip XR at MedsBase is supplied directly from a WHO-GMP certified manufacturer in plain, discreet packaging. Every order is covered by our \u00dajrak\u00fcld\u00e9si Garancia<\/a> \u2014 20 \u00fczleti napos \u00e9rkez\u00e9si ablak vagy ingyenes \u00fajrasz\u00e1ll\u00edt\u00e1s \u2014 \u00e9s jogosult a mi h\u0171s\u00e9gprogramunkra<\/a>. .<\/p>\n

What Palip XR is and how it works<\/h2>\n

Palip XR is a paliperidone extended-release tablet supplied by Sun Pharma. Available strengths: 3 \/ 6 \/ 9 mg XR<\/strong>. Paliperidone is the major active metabolite of risperidone (9-hydroxyrisperidone). Pharmacologically very similar \u2014 strong D2 and 5-HT2A antagonism, prolactin elevation, EPS at higher doses \u2014 but with two practical differences: (1) the OROS extended-release formulation produces a flat 24-hour plasma curve (smoother tolerability than risperidone IR), and (2) paliperidone is largely renally cleared (75%) rather than hepatically metabolised, so it is unaffected by CYP-altering drugs but requires dose adjustment in renal impairment.<\/p>\n

What Agoprex is and how it works<\/h2>\n\n\n\n\n\n\n\n\n\n\n
Agoprex is a 25 mg agomelatine tablet supplied by Sun Pharma. Agomelatine is mechanistically unique among antidepressants: it acts as an agonist at melatonin MT1 and MT2 receptors and an antagonist at 5-HT2C serotonin receptors. The dual mechanism resynchronises disrupted circadian rhythms (a feature of major depression) while indirectly increasing dopamine and noradrenaline release in the frontal cortex.<\/th>\nAgomelatine has no SERT activity, no anticholinergic effects, and no histaminergic effects \u2014 explaining its very different side-effect profile from SSRIs and TCAs.<\/th>\nIndications and dosing<\/th>\nIndication<\/th>\n<\/tr>\n<\/thead>\n
Skizofr\u00e9nia (feln\u0151tt)<\/td>\n6 mg OD morning<\/td>\n3\u201312 mg OD<\/td>\n12 mg<\/td>\n<\/tr>\n
Schizophrenia (adolescent \u2265 12 y, \u2265 51 kg)<\/td>\n3 mg OD<\/td>\n3\u201312 mg OD<\/td>\n12 mg<\/td>\n<\/tr>\n
Schizoaffective disorder<\/td>\n6 mg OD<\/td>\n3\u201312 mg OD<\/td>\n12 mg<\/td>\n<\/tr>\n
Renal impairment (CrCl 50\u201380)<\/td>\n3 mg OD<\/td>\nup to 6 mg<\/td>\n6 mg<\/td>\n<\/tr>\n
Renal impairment (CrCl 10\u201350)<\/td>\n1.5 mg OD<\/td>\nup to 3 mg<\/td>\n3 mg<\/td>\n<\/tr>\n
Veseel\u00e9gtelens\u00e9g (CrCl < 10)<\/td>\nnem aj\u00e1nlott<\/td>\n\u2014<\/td>\n\u2014<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Take whole \u2014 do not crush, chew, or split. The OROS osmotic pump shell will pass intact in stool \u2014 this is normal and expected.<\/p>\n

Fontos biztons\u00e1gi megfontol\u00e1sok<\/h2>\n
\nFDA fekete doboz \u2014 demenci\u00e1val \u00f6sszef\u00fcgg\u0151 pszich\u00f3zis<\/strong><\/p>\n

Az \u00f6sszes at\u00edpusos antipszichotikum hordoz egy FDA fekete doboz figyelmeztet\u00e9st a megn\u00f6vekedett hal\u00e1loz\u00e1si kock\u00e1zat miatt (f\u0151leg cardiovascularis \u00e9s fert\u0151z\u00e9ses okokb\u00f3l), amikor id\u0151s, demenci\u00e1ban szenved\u0151 betegek viselked\u00e9szavarainak kezel\u00e9s\u00e9re haszn\u00e1lj\u00e1k. Az at\u00edpusos antipszichotikumok nincsenek j\u00f3v\u00e1hagyva demenci\u00e1val \u00f6sszef\u00fcgg\u0151 pszich\u00f3zis vagy agit\u00e1ci\u00f3 kezel\u00e9s\u00e9re<\/strong>. Haszn\u00e1latuk ebben a popul\u00e1ci\u00f3ban off-label, utols\u00f3 lehet\u0151s\u00e9g, id\u0151korl\u00e1tozott, \u00e9s kifejezett kock\u00e1zat-haszon besz\u00e9lget\u00e9st ig\u00e9nyel.<\/p>\n<\/div>\n

\nHyperprolactinaemia (similar to risperidone)<\/strong><\/p>\n

As an active risperidone metabolite, paliperidone produces the same prolactin elevation: amenorrhoea, galactorrhoea, sexual dysfunction, and long-term bone-density loss. Monitor as for risperidone; switch to a prolactin-sparing atypical (aripiprazole, quetiapine) if symptomatic.<\/p>\n<\/div>\n

\nEPS \/ dose-dependent<\/strong><\/p>\n

Above 6 mg\/day, EPS and akathisia rise in frequency. Dose-dependent.<\/p>\n<\/div>\n

\nGI obstruction caveat<\/strong><\/p>\n

The non-deformable OROS tablet is theoretically problematic in pre-existing severe GI narrowing (severe Crohn’s strictures, oesophageal stricture, prior bowel resection). Rare clinically, but worth noting.<\/p>\n<\/div>\n

Gyakori mell\u00e9khat\u00e1sok<\/h2>\n